Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
Part of paid clinical trials in Irvine, California.
- Sponsor
- Immunis, Inc.
- Study ID
- NCT05211986
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Muscle Atrophy
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- IMM01-STEM — DRUGIMM01-STEM is a secretome product derived from partially differentiated pluripotent stem cells that contains regenerative molecules.
Study Details
An open-label dose escalation study to assess the safety and tolerability of IMM01-STEM in participants with muscle atrophy related to knee osteoarthritis
Key Dates
- Start date
- Sep 13, 2022
- Status verified
- Oct 2025
- Primary completion
- Mar 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 28 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Cohort AParticipants will receive twice weekly intramuscular (im) administration of IMM01-STEM for 4 weeks with a dose of 225μg.
- Active Comparator: Cohort BParticipants will receive twice weekly intramuscular (im) administration of IMM01-STEM for 4 weeks with a dose of 450μg.
- Active Comparator: Cohort CParticipants will receive twice weekly intramuscular (im) administration of IMM01-STEM for 4 weeks with a dose of 900μg.
- Active Comparator: Cohort DParticipants will receive twice weekly intramuscular (im) administration of IMM01-STEM for 4 weeks with a dose of 2000μg.
Primary Outcome Measure
Safety of IMMUNA(IMM01-STEM) treatment in study participants with muscle atrophy related to KOA [ Time Frame: Day 0 to Day 28 ]
Central Contacts
- Joelle Hafen, BS9492662501
- Erin Curry, PA9492662501
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Orthopaedic Specialty Institute | Irvine | California | 92618 | Adam Rivadeneyra, MD (PRINCIPAL_INVESTIGATOR) |
| University of California, Irvine - Alpha Stem Cell Clinic | Orange | California | 92868 | - |
Find similar trials in Irvine, CA
Related Studies
- Impact of NMES and HPRO on Recovery After SAH- Pilot StudyRecruiting · University of Maryland, Baltimore · Baltimore, Maryland
- The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older AdultsRecruiting · AdventHealth Translational Research Institute · Orlando, Florida
- A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart FailureRecruiting · Tufts Medical Center · Boston, Massachusetts
- Essential Amino Acid Supplementation for Femoral Fragility FracturesPHASE2 · Recruiting · Michael C Willey · Iowa City, Iowa